SeaStar Medical Holding Corporation is facing a significant challenge as it received a notice from Nasdaq regarding its listing status. The company was informed that it is not in compliance with Nasdaq's minimum stockholder's equity requirement, which mandates that companies maintain at least $2.5 million in stockholder's equity. This notification comes after the company’s latest quarterly report indicated it did not meet this threshold.

The notice, dated November 20, 2026, indicates that SeaStar Medical has until January 4, 2027, to submit a compliance plan to address this issue. If the plan is accepted by Nasdaq, the company could receive an extension of up to 180 days to regain compliance. However, there is no guarantee that the compliance plan will be accepted, nor that the company will be able to meet the requirements within the allotted time.

Company Background

SeaStar Medical Holding Corp operates within the surgical and medical instruments and apparatus sector, classified under SIC 3841. The company is listed on the Nasdaq under the ticker symbols ICU and ICUCW. It is categorized as a smaller reporting company and an emerging growth company. The firm has been active in the medical technology space, focusing on innovative solutions to improve patient outcomes.

What the Filing Says

The filing states, "the Company is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market with a market value of listed securities of less than $35 million and annual net income of less than $500,000 to maintain a minimum of $2.5 million in stockholder's equity for continued listing." The company plans to submit a compliance plan to address these issues.

Impact

This situation could affect SeaStar Medical's investors and stakeholders, as well as its standing in the surgical and medical instruments industry. If the company is unable to regain compliance, it risks being delisted from the Nasdaq, which could lead to a loss of investor confidence and a decline in market visibility.

What's Next

The company has until January 4, 2027, to submit its compliance plan. If accepted, it may receive an extension to meet the stockholder's equity requirement. The filing does not specify what happens next if the plan is rejected.